Circio Holding
Be the first to follow this company
Circio Holding is a pharmaceutical company. The company's specialist expertise is in targeted immunotherapy used in the treatment of cancer patients. The company's operations consist of research and development and the pharmaceuticals are currently sold under separate brands. Several partnerships in the market have been entered to strengthen cooperation in the development of new immunotherapy. The company was founded in 2010 and is headquartered in Lysaker.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Oslo Børs
CRNA
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
Interim report
2024-08-29
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Hose | 7.7 % | 7.7 % |
Nordnet Bank | 2.8 % | 2.8 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Circio Holding ASA - Information about the warrants issued in connection with the rights issue and new share capital registered
Circio Holding ASA - New share capital registered following rights issue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools